Evidence
Am J Psychiatry. 2023 May 1;180(5):340-347. doi: 10.1176/appi.ajp.20230172.
ABSTRACT
Over the past decade, psychedelic compounds have emerged as potentially transformative therapeutics for a variety of intractable neuropsychiatric conditions. However, historically most of the basic science has utilized these compounds as probes to interrogate various endogenous neurotransmitter systems-mainly the serotonin 5-HT2A receptor. With the renewed interest in utilizing these compounds as therapeutics and the explosion in clinical trials, psychedelics have been purported to treat many neuropsychiatric disorders, including depression, cluster headaches, migraines, anxiety, and obsessive-compulsive disorder. It is therefore imperative to understand the biology and pharmacology behind their therapeutic mechanisms as well as expose any potential pitfalls in their widespread use as treatments. This review covers the latest advances in understanding the biological mechanisms, the newest efforts in drug discovery, and potential pitfalls when it comes to utilizing this class of compounds as emerging therapeutics.
PMID:37122272 | DOI:10.1176/appi.ajp.20230172
Add to Google Keep
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence ☀️
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Psychedelics as Transformative Therapeutics
🌐 90 Days
VR Related Evidence Matrix
- Structural pharmacology and therapeutic potential of 5-methoxytryptamines
- Structural pharmacology and therapeutic potential of 5-methoxytryptamines
- Psychedelic Therapy: A Primer for Primary Care Clinicians-The Strengths, Weaknesses, Opportunities, and Threats of Psychedelic Therapeutics
- Multimodal Neuroimaging of the Effect of Serotonergic Psychedelics on the Brain
- Discovery and in vitro Evaluation of Novel Serotonin 5-HT2A Receptor Ligands Identified Through Virtual Screening
- RNA therapeutics for neurological disease
- Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis
- Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis
- Past Is Prologue: Ethical Issues in Pediatric Psychedelics Research and Treatment
- 4-Amidophenol Quinone Methide Precursors: Effective and Broad-Scope Nonoxime Reactivators of Organophosphorus-Inhibited Cholinesterases and Resurrectors of Organophosphorus-Aged Acetylcholinesterase
- The Developmental Trajectory to Cannabis Use Disorder
- The Developmental Trajectory to Cannabis Use Disorder
- The Influence of Parenting on Callous-Unemotional Traits and the Implications for the Causes and Treatment of Conduct Disorder
- In the new era of psychedelic assisted therapy: A systematic review of study methodology in randomized controlled trials
- The Influence of Parenting on Callous-Unemotional Traits and the Implications for the Causes and Treatment of Conduct Disorder
- Are "mystical experiences" essential for antidepressant actions of ketamine and the classic psychedelics?
- Pharmacological fingerprint of antipsychotic drugs at the serotonin 5-HT2A receptor
- Primordial Origins of RNA Therapeutics
- Predicting Conversion to Psychosis: What Lies Beyond the Biomarkers?
- The advent of RNA-based therapeutics for metabolic syndrome and associated conditions: a comprehensive review of the literature
- Scoping Review: The Role of Psychedelics in the Management of Chronic Pain
- Psychedelic-assisted therapy for people with gambling disorder?
- COVID-19 anxiety and its relation to anxiety-related disorder symptoms and mechanisms
- Selective alterations of endocannabinoid system genes expression in obsessive compulsive disorder
- Adolescent Psychedelic Use and Psychotic or Manic Symptoms
- Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin
- Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms
- Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms
- Nutritional profiling and in silico analysis of pharmacological activities from local rice Pulu Mandoti fermented with Pleurotus spp
- Understanding the Unfolded Protein Response (UPR) Pathway: Insights into Neuropsychiatric Disorders and Therapeutic Potentials
- Natural compounds mitigate mycotoxins-induced neurotoxicity by modulating oxidative tonus: in vitro and in vivo insights - a review
- Neuroimaging correlates of classical psychedelics effects: A systematic review
- Neuroimaging correlates of classical psychedelics effects: A systematic review
- A review of the ethnopharmacology, phytochemistry, pharmacology, pharmacokinetics and toxicology of Abri Herba (Ji-Gu-Cao)
- Insomnia in Forensic Detainees: Is Salience Network the Common Pathway for Sleep, Neuropsychiatric, and Neurodegenerative Disorders?
- Phytocannabinoids in neuromodulation: from omics to epigenetics
- Kaempferol efficacy in metabolic diseases: Molecular mechanisms of action in diabetes mellitus, obesity, non-alcoholic fatty liver disease, steatohepatitis, and atherosclerosis
- Natural compounds proposed for the management of non-alcoholic fatty liver disease
- Affective disorders and the loudness dependence of the auditory evoked potential: Serotonin and beyond
- Population-based cohort study of Toxoplasma gondii P22 antibody positivity correlation with anxiety
- AI in Pharma: Transforming Drug Discovery and Strategic Management with MYC-Modulating Compounds and BET Protein Inhibitors
- Role of Serotonylation and SERT Posttranslational Modifications in Alzheimer's Disease Pathogenesis
- Advances in understanding migraine pathophysiology: a bench to bedside review of research insights and therapeutics
- An Extensive Review on Lung Cancer Therapeutics Using Machine Learning Techniques: State-of-the-art and Perspectives
- Crocin (bioactive compound of Crocus sativus L.) potently restores REM sleep deprivation-induced manic- and obsessive-compulsive-like behaviors in female rats
- Network pharmacology and experimental evidence: ERK/CREB/BDNF signaling pathway is involved in the antidepressive roles of Kaiyu Zhishen decoction
- Integrated spatial metabolomics and transcriptomics decipher the hepatoprotection mechanisms of wedelolactone and demethylwedelolactone on non-alcoholic fatty liver disease
- Network pharmacology combined with molecular docking and experimental verification to elucidate the effect of flavan-3-ols and aromatic resin on anxiety
- From compulsivity to compulsion: the neural basis of compulsive disorders
- New horizons for the study of saffron (Crocus sativus L.) and its active ingredients in the management of neurological and psychiatric disorders: A systematic review of clinical evidence and mechanisms
- Orexins and primary headaches: an overview of the neurobiology and clinical impact
- Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder
- Structural mechanisms for VMAT2 inhibition by tetrabenazine
- Chandipura Viral Glycoprotein (CNV-G) Promotes Gectosome Generation and Enables Delivery of Intracellular Therapeutics
- Obsessive-Compulsive Symptoms: Baseline Prevalence, Comorbidity, and Implications in a Clinically Anxious Pediatric Sample
- Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
- Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
- How can we manage progressive supranuclear palsy syndrome with pharmacotherapy?
- Cognitive Impulsivity in Anorexia Nervosa in Correlation with Eating and Obsessive Symptoms: A Comparison with Healthy Controls
- Insight in obsessive-compulsive disorder: conception, clinical characteristics, neuroimaging, and treatment
- Unveiling the Molecular Interactions Between Human Transferrin and Limonene: Natural Compounds in Alzheimer's Disease Therapeutics
- Pharmacotherapy of Chronic Neuropsychiatric Conditions During Pregnancy
- Exploration of carbonyl compounds in red-fleshed kiwifruit wine and perceptual interactions among non-volatile organic acids
- OUCAGS Forum - 'NIHR Experimental Medicine Clinical Research Facility - what is it and how can it help deliver my research?'
Evidence Blueprint
Psychedelics as Transformative Therapeutics
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Psychedelics as Transformative Therapeutics
🌐 365 Days
VR Related Evidence Matrix
- Structural pharmacology and therapeutic potential of 5-methoxytryptamines
- Structural pharmacology and therapeutic potential of 5-methoxytryptamines
- Psychedelic Therapy: A Primer for Primary Care Clinicians-The Strengths, Weaknesses, Opportunities, and Threats of Psychedelic Therapeutics
- Psychedelic Drugs or Hallucinogens: Exploring Their Medicinal Potential
- Perceptual Modifying Compounds and Their Potential Therapeutic Applications in Neuropsychiatric Disorders
- Bedside to bench: the outlook for psychedelic research
- Overview of Alcohol Use Disorder
- Addressing the Current Knowledge and Gaps in Research Surrounding Lysergic Acid Diethylamide (LSD), Psilocybin, and Psilocin in Rodent Models
- Cerebrovascular Disease and Neuropsychiatric Disorders: Translating Findings From the MRI Scanner to the Clinic
- The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
- Psychedelics for Alzheimer's Disease-Related Dementia: Unveiling Therapeutic Possibilities and Pathways
- Therapeutic potential of stilbenes in neuropsychiatric and neurological disorders: A comprehensive review of preclinical and clinical evidence
- Psychedelics reopen the social reward learning critical period
- Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics
- Classical psychedelics in psychiatry - renaissance of interest and therapeutic perspectives
- Multimodal Neuroimaging of the Effect of Serotonergic Psychedelics on the Brain
- Discovery and in vitro Evaluation of Novel Serotonin 5-HT2A Receptor Ligands Identified Through Virtual Screening
- Cardiovascular safety of psychedelic medicine: current status and future directions
- RNA therapeutics for neurological disease
- Substance Use Disorders Are Psychiatric Disorders
- Isolating Socioenvironmental Correlates of Race/Ethnicity: A Promising Strategy to Understand and Address Health Disparities
- Rethinking the First Episode of Schizophrenia: Identifying Convergent Mechanisms During Development and Moving Toward Prediction
- New Insights Into Psychotic Disorders
- The First Large GWAS Meta-Analysis for Postpartum Depression
- Adversity and Resilience, Postpartum Depression, Suicide, and Racial/Ethnic Disparities
- Improvement in OCD symptoms associated with serotoninergic psychedelics: a retrospective online survey
- Seeking New Solutions Addressing Structural Racism, Childhood Trauma, Suicidal Behaviors Across Sexual Orientations, and Postpartum Depression
- Alcohol Consumption and Alcohol Use Disorder: Exposing an Increasingly Shared Genetic Architecture
- Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis
- Psychedelia: The interplay of music and psychedelics
- Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis
- Correction to Guintivano et al
- Sutton's Law
- Sexual Orientation and Suicidal Behavior: Is It Getting Better?
- Predicting Conversion to Psychosis Using Machine Learning: Are We There Yet?
- Molecular and Medical Aspects of Psychedelics
- Perinatal Mental Health: Advances and Opportunities
- Another Step Toward the Prediction of Antipsychotic Treatment Response Using Functional Connectivity
- Trends in Suicide Among Black Women in the United States, 1999-2020
- Past Is Prologue: Ethical Issues in Pediatric Psychedelics Research and Treatment
- Early-life Adversity and Genetics Associated With the Risk to Develop Psychiatric Illnesses
- A Mental Health Crisis and Call to Action: Increasing Trends in Suicide Among Black Women in the United States
- From Postmortem Molecular Studies to Social Determinants of Health Relevant to Racial and Ethnic Disparities
- Neuropsychiatric Manifestations of Mast Cell Activation Syndrome and Response to Mast-Cell-Directed Treatment: A Case Series
- Dissecting the Relationship Between Neuropsychiatric and Neurodegenerative Disorders
- Addiction specialists' attitudes toward psychedelics: A National Survey
- Psychedelics, Meaningfulness, and the "Proper Scope" of Medicine: Continuing the Conversation
- Modulation of neural circuits by melatonin in neurodegenerative and neuropsychiatric disorders
- 4-Amidophenol Quinone Methide Precursors: Effective and Broad-Scope Nonoxime Reactivators of Organophosphorus-Inhibited Cholinesterases and Resurrectors of Organophosphorus-Aged Acetylcholinesterase
- The bodily self from psychosis to psychedelics
- Identification of drug repurposing candidates for the treatment of anxiety: A genetic approach
- Psychedelics to Relieve Psychological Suffering Associated with a Life-Threatening Diagnosis: Time for a Canadian Policy Discussion
- The Developmental Trajectory to Cannabis Use Disorder
- The Developmental Trajectory to Cannabis Use Disorder
- Molecular Mechanism Pathways of Natural Compounds for the Treatment of Non-Alcoholic Fatty Liver Disease
- The Influence of Parenting on Callous-Unemotional Traits and the Implications for the Causes and Treatment of Conduct Disorder
- Novel neurosteroid therapeutics for post-partum depression: perspectives on clinical trials, program development, active research, and future directions
- In the new era of psychedelic assisted therapy: A systematic review of study methodology in randomized controlled trials
- Pharmacology of platelet immune receptors: mechanisms of activation and development of therapeutics
- Psychedelics and neonihilism: connectedness in a meaningless world
- The Influence of Parenting on Callous-Unemotional Traits and the Implications for the Causes and Treatment of Conduct Disorder
- Are "mystical experiences" essential for antidepressant actions of ketamine and the classic psychedelics?
- Psychedelic therapy in the treatment of addiction: the past, present and future
- The Serotonin 1A (5-HT1A) Receptor as a Pharmacological Target in Depression